This content is machine translated Neurodegenerative disease Football better with head protection in the future? A study from Scotland shows that professional football players have a 3.5 times higher risk of developing a neurodegenerative disease later in life compared to the general population. Players in…
View Post 3 min This content is machine translated Spinal muscular atrophy in infants (SMA type 1) European study confirms effectiveness Spinal muscular atrophy type 1 (SMA1) is a congenital neurological disorder with severe muscle weakness and wasting (muscle atrophy). Untreated, affected children barely reach the age of three. However, treatment…
View Post 2 min This content is machine translated Neuroimmunology Podcasts provide insight into rare diseases Rare diseases have one thing in common: only a few people are really familiar with the symptoms and possible treatment options. Three different podcasts now take you into the exciting…
View Post 2 min This content is machine translated Spinal muscular atrophy Single-agent gene therapy shows transformative therapeutic benefit New trial data demonstrate age-appropriate development and achievement of motor milestones in presymptomatic children with SMA using single-agent gene therapy, without any respiratory or nutritional support or serious treatment-related adverse…
View Post 3 min This content is machine translated Multiple sclerosis Future prospects: focus on personalized therapy Approximately 15,000 people in Switzerland are diagnosed with multiple sclerosis. The disease is not yet curable. Still. This is because ever better knowledge of the pathophysiology of the disease is…
View Post 4 min This content is machine translated "Mild Cognitive Impairment" (MCI). Ginkgo biloba for the improvement of neurocognitive symptoms Patients with mild cognitive function impairment – mostly affecting those over 60 years of age – may benefit from symptomatic therapy based on a standardized extract of ginkgo. This is…
View Post 3 min This content is machine translated Dementia Still forgetful or already demented? Effective treatment from the beginning The first signs of dementia are often not recognized, because the changes in the brain occur gradually. Often, a depressive episode also masks the actual symptoms. However, in order to…
View Post 4 min This content is machine translated Epilepsy Modern treatment management focuses on monotherapy The range of therapies for generalized and especially focal epilepsies is constantly expanding, so that the treatment regime can now be individually adapted to the needs of those affected. However,…
View Post 3 min This content is machine translated Parkinson's disease What is still possible when seemingly nothing else works Contemporary Parkinson’s therapy is multidisciplinary and is based on the individual needs of the patient. The experts at the dgp-Congress agreed. Increasing understanding of disease progression will enable personalized treatment,…
View Post 10 min This content is machine translated Sponsored Content: 5q-associated spinal muscular atrophy (5q-SMA). Nusinersen: Central to CNS, targeted effect. The antisense oligonucleotide nusinersen was approved in 2017 as the first drug for the causal treatment of patients with 5q-associated spinal muscular atrophy (5q-SMA) [1]. The drug targets the cause…
View Post 3 min This content is machine translated Multiple sclerosis Diagnosis, differential diagnosis and treatment up to date Depending on its course, multiple sclerosis can lead to rapid losses in quality of life. Research is working at full speed to further detect the pathology of the disease and…
